Total population (n = 10) | |
---|---|
General characteristics | |
Gender, male; n (%) | 9 (90) |
Age, years; mean (SD) | 71.7 (6) |
Former smoker, n (%) | 8 (80) |
BMI, kg/m2; mean (SD) | 28.5 (5) |
GAP index, median (p25-p75) | 3 (2–3) |
Treatments, n (%) | |
Antifibrotic therapy | 9 (90) |
Ambulatory oxygen therapy on exertion | 8 (80) |
Ambulatory 24-h oxygen therapy | 4 (40) |
Comorbidities, n (%) | |
Hypertension | 4 (40) |
Dyslipidemia | 4 (40) |
Diabetes mellitus | 3 (30) |
Sleep apnea | 2 (20) |
Ischemic heart disease | 2 (20) |
Pulmonary emphysema | 2 (20) |
Pulmonary hypertensiona | 4 (40) |
Charlson comorbidity index; mean (SD) | 4.1 (1.2) |
Pulmonary function tests, mean (SD) | |
FEV1, % pred | 62 (13) |
FVC, % pred | 58 (11) |
DLCO, % pred | 31 (13) |
6-min walking test, mean (SD) | |
Distance, m | 436 (131) |
Distance, % pred | 90 (20) |
Initial SpO2, % | 91 (4) |
Minimum SpO2, % | 76 (7) |
Mean SpO2, % | 81 (4) |
ΔSpO2, %b | − 18 (10) |
Peripheral muscle strength, mean (SD) | |
Quadriceps strength, kg | 41 (14) |
Quadriceps strength, % pred | 109 (39) |
Hand-grip, kg | 30 (12) |
Hand-grip, % pred | 111 (30) |